A case of fungal keratitis: a clinical and in vivo confocal microscopy assessment.
A presumed case of fungal keratitis is presented. Confocal images highlight the advantage of using such technology to follow therapeutic progress, particularly when standard laboratory testing is inconclusive. This case also demonstrates the importance of continued patient education regarding overall compliance and lens care.
Miller
William L
WL
University of Houston, College of Optometry, 505 J. Davis Armistead Building, Houston, TX 77204-2020, United States. wmiller@uh.edu
Giannoni
Amber Gaume
AG
Perrigin
Judith
J
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001372:Aza Compounds / Q000627:therapeutic use; D003320:Corneal Ulcer / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D004359:Drug Therapy, Combination; D015821:Eye Infections, Fungal / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D024841:Fluoroquinolones; D005670:Fusarium; D006801:Humans; D008297:Male; D018613:Microscopy, Confocal; D000077266:Moxifloxacin; D009181:Mycoses / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D010866:Natamycin / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D014031:Tobramycin / Q000627:therapeutic use
D000890:Anti-Infective Agents; D000935:Antifungal Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D010866:Natamycin; D000077266:Moxifloxacin; D014031:Tobramycin